Anti-TNF therapy in alcoholic hepatitis.
Hill
Daniell B
DB
McClain
Craig J
CJ
D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D000068800:Etanercept; D006519:Hepatitis, Alcoholic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D010431:Pentoxifylline / Q000627:therapeutic use*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D004791:Enzyme Inhibitors; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept; D010431:Pentoxifylline